PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?

Due to its overexpression on the surface of prostate cancer cells, prostate-specific membrane antigen (PSMA) is a relatively novel effective target for molecular imaging and radioligand therapy (RLT) in prostate cancer. Recent studies reported that PSMA is expressed in the neovasculature of various...

Full description

Bibliographic Details
Main Authors: Alessio Rizzo, Sara Dall’Armellina, Daniele Antonio Pizzuto, Germano Perotti, Luca Zagaria, Valerio Lanni, Giorgio Treglia, Manuela Racca, Salvatore Annunziata
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
PSMA
PET
theragnostics
therapy
radioligand
nuclear medicine
Online Access:https://www.mdpi.com/2072-6694/14/16/4039

Internet

https://www.mdpi.com/2072-6694/14/16/4039

Similar Items